Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

ERBB4 G1109C

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

ERBB4 H809G + ER positive (1)

ERBB4 mutation + HER-2 positive (1)

ERBB4 H809G + ER positive (1)

ERBB4 mutation + HER-2 positive (1)

›

ERBB4 G1109C	Head and Neck Cancer	ERBB4 G1109C	Head and Neck Cancer	afatinib Sensitive: D – Preclinical afatinib Sensitive : D	afatinib Sensitive: D – Preclinical afatinib Sensitive : D
ERBB4 G1109C	Esophageal Cancer	ERBB4 G1109C	Esophageal Cancer	erlotinib Resistant: D – Preclinical erlotinib Resistant : D	erlotinib Resistant: D – Preclinical erlotinib Resistant : D
ERBB4 G1109C	Esophageal Cancer	ERBB4 G1109C	Esophageal Cancer	cetuximab Resistant: D – Preclinical cetuximab Resistant : D	cetuximab Resistant: D – Preclinical cetuximab Resistant : D
ERBB4 G1109C	Esophageal Cancer	ERBB4 G1109C	Esophageal Cancer	afatinib Sensitive: D – Preclinical afatinib Sensitive : D	afatinib Sensitive: D – Preclinical afatinib Sensitive : D
ERBB4 G1109C	Squamous Cell Carcinoma of Head and Neck	ERBB4 G1109C	Squamous Cell Carcinoma of Head and Neck	afatinib Sensitive: D – Preclinical afatinib Sensitive : D	afatinib Sensitive: D – Preclinical afatinib Sensitive : D